Literature DB >> 12072405

Mechanism of androgen action on cell proliferation: AS3 protein as a mediator of proliferative arrest in the rat prostate.

Maricel V Maffini1, Peter Geck, Charles E Powell, Carlos Sonnenschein, Ana M Soto.   

Abstract

Androgens control the proliferation of their target cells first by increasing cell proliferation and later by inhibiting the proliferation of those same cells. Recently, we reported that the AS3 protein mediates the androgen-induced quiescence in androgen-target human cell lines. Our aims were to investigate the expression of the AS3 protein in the rat prostate in situ and in human cells in culture. Adult rats were separated into four groups (intact, castrated, castrated plus 3-d testosterone propionate replacement, and castrated plus 7-d testosterone propionate replacement). S9 cells expressing a tetracycline-regulated sense AS3 were also used. AS3 was expressed in the nuclei of over 90% of the epithelial cells and about 40% of the smooth muscle cells of the intact rat prostate. AS3 was not expressed in castrated rats or during the proliferative phase of androgen-induced regeneration. It was expressed in intact and castrated animals when the prostate has reached adult organ size. The AS3 protein was not expressed in cells that incorporate bromodeoxyuridine. These data suggest that AS3 is a mediator of the proliferative arrest in the normal rat prostate in situ and human prostate cell lines and that its expression is androgen-induced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072405     DOI: 10.1210/endo.143.7.8899

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

Authors:  Maricel Maffini; Viktoria Denes; Carlos Sonnenschein; Ana Soto; Peter Geck
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-12       Impact factor: 4.292

2.  Overexpression of APRIN inhibits differentiation and proliferation and promotes apoptosis in P19 embryonal carcinoma cells.

Authors:  Xiang Zhou; Xiangqing Kong; Weiting Xu; Jianchang Chen
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

3.  Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer.

Authors:  Michael T Schweizer; Emmanuel S Antonarakis; Samuel R Denmeade
Journal:  Eur Urol       Date:  2017-03-29       Impact factor: 20.096

4.  Large scale phosphoproteome analysis of LNCaP human prostate cancer cells.

Authors:  Jae-Kyung Myung; Marianne D Sadar
Journal:  Mol Biosyst       Date:  2012-06-14

Review 5.  From Wingspread to CLARITY: a personal trajectory.

Authors:  Ana M Soto; Cheryl M Schaeberle; Carlos Sonnenschein
Journal:  Nat Rev Endocrinol       Date:  2021-01-29       Impact factor: 47.564

6.  Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer.

Authors:  Hung-Ming Lam; Eva Corey
Journal:  Front Oncol       Date:  2018-05-22       Impact factor: 6.244

7.  A Combined Morphometric and Statistical Approach to Assess Nonmonotonicity in the Developing Mammary Gland of Rats in the CLARITY-BPA Study.

Authors:  Maël Montévil; Nicole Acevedo; Cheryl M Schaeberle; Manushree Bharadwaj; Suzanne E Fenton; Ana M Soto
Journal:  Environ Health Perspect       Date:  2020-05-20       Impact factor: 9.031

8.  Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells.

Authors:  Dimiter Kunnev; Igor Ivanov; Yurij Ionov
Journal:  BMC Cancer       Date:  2009-09-08       Impact factor: 4.430

9.  Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer.

Authors:  Wenjuan Mo; Jiyuan Zhang; Xia Li; Delong Meng; Yun Gao; Shu Yang; Xuechao Wan; Caihong Zhou; Fenghua Guo; Yan Huang; Stefano Amente; Enrico V Avvedimento; Yi Xie; Yao Li
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

Review 10.  Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.

Authors:  Osama S Mohammad; Michael D Nyquist; Michael T Schweizer; Stephen P Balk; Eva Corey; Stephen Plymate; Peter S Nelson; Elahe A Mostaghel
Journal:  Cancers (Basel)       Date:  2017-12-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.